Related Experiment Video

Updated: Jun 21, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Recent advances in the treatment of follicular lymphoma

Yukio Kobayashi1

  • 1Hematology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. ykkobaya@ncc.go.jp

International Journal of Clinical Oncology
|July 14, 2009
PubMed

Insights

New therapies for follicular lymphoma are emerging, including advanced anti-CD20 antibodies and repurposed agents. Clinical trials for these novel treatments are actively underway, showing promising developments in cancer research.

Area of Science:

  • Oncology
  • Immunotherapy
  • Hematology

Background:

  • Anti-CD20 monoclonal antibody therapy has shown success in treating follicular lymphoma.
  • This success drives the search for new molecular targets and more potent antibody therapies.
  • Agents initially developed for other cancers are also proving effective against follicular lymphoma.

Purpose of the Study:

  • To review emerging therapeutic agents for follicular lymphoma.
  • To highlight new antibody-based therapies and repurposed chemical compounds.
  • To note the ongoing clinical trials of these agents, including those in Japan.

Main Methods:

  • Literature review of current research on follicular lymphoma treatments.
  • Introduction of novel therapeutic agents, including antibodies and chemical compounds.
  • Summary of ongoing clinical trial data for new agents.

Main Results:

  • A new generation of potent antibodies targeting CD20 and other molecules is under development.
  • Repurposed chemical compounds demonstrate efficacy in treating follicular lymphoma.
  • Clinical trials for these novel agents are actively progressing.

Conclusions:

  • The landscape of follicular lymphoma treatment is expanding with new therapeutic options.
  • Ongoing clinical trials are crucial for evaluating the efficacy and safety of these emerging agents.
  • International collaboration, including trials in Japan, contributes to advancing follicular lymphoma therapy.

More Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.